Xeris Pharmaceuticals (XERS) Gains Momentum From The Recent Lows

Specialty pharmaceutical company Xeris Pharmaceuticals Inc (NASDAQ: XERS) seems to have come back into focus among investors after having hit its recent lows.

The Xeris stock has managed to gain considerable momentum in recent days and hence, it might be a good idea for investors to start tracking it. In this regard, it might be a good move for investors to check out development from back on March 11. The company announced the pricing of its registered direct offering of 6,553,398 shares of its common stock.

Related:  Happiness Biotech Group (HAPP) Stock Is All Set To Gap Up Today

The shares are going to be bought by funds that are controlled by an existing investor in the company Deerfield Management Company LP. The shares are going to offer at a price of $4.12 each and the offering in question is going to raise as big as $27 million for Xeris. It goes without saying that this is a significant development for Xeris and could have resulted in the recent momentum in the stock.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.